Page last updated: 2024-08-16

mitomycin and pevonedistat

mitomycin has been researched along with pevonedistat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hagen, T; Tan, CY	1
Bandi, S; Blank, JL; Bouck, DC; Cosmopoulos, K; Garcia, K; Hather, G; Kuranda, M; Lightcap, ES; Liu, R; Liu, XJ; Pickard, MD; Sappal, DS; Smith, PG; Thomas, MP	1

Other Studies

2 other study(ies) available for mitomycin and pevonedistat

Article	Year
Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases. The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:7 Topics: Cell Cycle Proteins; Cullin Proteins; Cyclopentanes; DNA Damage; DNA Replication; G1 Phase; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Mitomycin; NEDD8 Protein; Nuclear Proteins; Pyrimidines; RNA Interference; RNA, Small Interfering; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitination; Ubiquitins	2013
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathways. Molecular cancer therapeutics, 2014, Volume: 13, Issue:6 Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Chromatin; Cyclopentanes; DNA Damage; Drug Synergism; Humans; Mice; Mitomycin; Pyrimidines; Ubiquitin-Activating Enzymes; Ultraviolet Rays; Xenograft Model Antitumor Assays	2014

Article

Year

Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases.

The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:7

Topics: Cell Cycle Proteins; Cullin Proteins; Cyclopentanes; DNA Damage; DNA Replication; G1 Phase; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Mitomycin; NEDD8 Protein; Nuclear Proteins; Pyrimidines; RNA Interference; RNA, Small Interfering; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitination; Ubiquitins

2013

Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathways.

Molecular cancer therapeutics, 2014, Volume: 13, Issue:6

Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Chromatin; Cyclopentanes; DNA Damage; Drug Synergism; Humans; Mice; Mitomycin; Pyrimidines; Ubiquitin-Activating Enzymes; Ultraviolet Rays; Xenograft Model Antitumor Assays

2014